ATE173927T1 - Transdermal alfuzosin enthaltendes arztneimittel - Google Patents

Transdermal alfuzosin enthaltendes arztneimittel

Info

Publication number
ATE173927T1
ATE173927T1 AT93401896T AT93401896T ATE173927T1 AT E173927 T1 ATE173927 T1 AT E173927T1 AT 93401896 T AT93401896 T AT 93401896T AT 93401896 T AT93401896 T AT 93401896T AT E173927 T1 ATE173927 T1 AT E173927T1
Authority
AT
Austria
Prior art keywords
product containing
medicinal product
alfuzosine
transdermal
transdermal medicinal
Prior art date
Application number
AT93401896T
Other languages
English (en)
Inventor
Veronique Andrieu
Louis Henrion
Jean Montel
Alexander Wick
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of ATE173927T1 publication Critical patent/ATE173927T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
AT93401896T 1992-08-05 1993-07-22 Transdermal alfuzosin enthaltendes arztneimittel ATE173927T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9209711A FR2694495B1 (fr) 1992-08-05 1992-08-05 Préparation pharmaceutique transdermique contenant de l'alfuzosine.

Publications (1)

Publication Number Publication Date
ATE173927T1 true ATE173927T1 (de) 1998-12-15

Family

ID=9432638

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93401896T ATE173927T1 (de) 1992-08-05 1993-07-22 Transdermal alfuzosin enthaltendes arztneimittel

Country Status (10)

Country Link
US (1) US5523094A (de)
EP (1) EP0582502B1 (de)
JP (1) JP3723233B2 (de)
AT (1) ATE173927T1 (de)
CA (1) CA2101871C (de)
DE (1) DE69322328T2 (de)
DK (1) DK0582502T3 (de)
ES (1) ES2127261T3 (de)
FR (1) FR2694495B1 (de)
GR (1) GR3029315T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
US5614210A (en) * 1995-03-31 1997-03-25 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of alfuzosin
IL120303A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
IL120302A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
US6177430B1 (en) 1997-03-27 2001-01-23 Pfizer Inc Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
US5879701A (en) * 1997-02-28 1999-03-09 Cygnus, Inc. Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
FR2789586A1 (fr) * 1999-02-16 2000-08-18 Synthelabo Composition pharmaceutique pour administration transmucosale balanique d'alfuzosine
GB2352971A (en) * 1999-06-11 2001-02-14 Bambour Olubukola Omoyiola Transdermal administration of pharmaceuticals in prostate cancer and genito-urinary treatment
WO2002054996A2 (en) * 2000-10-23 2002-07-18 Euro Celtique Sa Terazosin transdermal device and methods
DE10359073B4 (de) * 2003-12-17 2006-03-02 Daimlerchrysler Ag Abgaskrümmer
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
FR2926466B1 (fr) * 2008-01-23 2010-11-12 Dbv Tech Procede de fabrication de patchs par electrospray
CN116080189B (zh) * 2022-11-08 2024-12-03 南通大学 一种耐折叠高剥离覆铝织物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
FR2421888A1 (fr) * 1978-02-06 1979-11-02 Synthelabo Amides d'alkylene-diamines et leur application en therapeutique
FR2582513B1 (fr) * 1985-05-28 1988-08-05 Synthelabo Compositions pharmaceutiques contenant de l'alfuzosine
LU86672A1 (fr) * 1986-11-19 1988-06-13 Oreal Composition pour induire et stimuler la croissance des cheveux et diminuer la chute a base de derives d'alkylene diamino quinazoline

Also Published As

Publication number Publication date
CA2101871A1 (fr) 1994-02-06
JP3723233B2 (ja) 2005-12-07
FR2694495B1 (fr) 1994-09-23
CA2101871C (fr) 2004-05-25
JPH06157315A (ja) 1994-06-03
EP0582502B1 (de) 1998-12-02
DK0582502T3 (da) 1999-08-16
EP0582502A1 (de) 1994-02-09
ES2127261T3 (es) 1999-04-16
GR3029315T3 (en) 1999-05-28
FR2694495A1 (fr) 1994-02-11
US5523094A (en) 1996-06-04
DE69322328T2 (de) 1999-06-24
DE69322328D1 (de) 1999-01-14

Similar Documents

Publication Publication Date Title
DE69322328D1 (de) Transdermal Alfuzosin enthaltendes Arztneimittel
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
DE69005951D1 (de) Medikamente enthaltend Salmeterol und Fluticason.
DE69011059D1 (de) Heterozyklische Acylaminothiazolderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen.
ID26956A (id) Pencegahan raf kinase menggunakan simetris dan nonsimetris yang digantikan diphenil urea
SE8804629D0 (sv) New therapeutically active compounds
DK254787A (da) Farmaceutiske praeparater til behandling af sygdomme foraarsaget af oxidativt stress og indeholdende 2-phenyl.1,2-benziso-selenazol-3(2h)-on som aktiv bestanddel
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
DK2689A (da) Farmaceutisk praeparat
ATE78812T1 (de) Diarylverbindungen als antiatherosklerotische mittel.
DE69228674D1 (de) Nichtsteroide-entzündungshemmende Arzneimittel und Decongestirum enthaltende Augenarzneimittelzusammensetzung
DE69322251D1 (de) Medizinische zusammensetzung
DE69107493D1 (de) Arzneimittel zur transdermalen Verabreichung von Nitroglycerin.
FI951789A0 (fi) Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
DK0825857T3 (da) Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse
BR9809234A (pt) Composto, composição farmacêutica, uso de um composto, processos para tratar ou prevenir doenças do sistema endocrinológico, para fabricar um medicamento, para preparar um composto e um conjunto, conjunto, e, uso do mesmo.
ATE297396T1 (de) Neue atropisomere von 2,3-disubstituierten-(5,6)- heteroarylkondensierten-pyrimidin-4-onen
ATE172969T1 (de) Polyzyklische aromatische verbindungen, sie enthaltende pharmazeutische und kosmetische zusammensetzungen und deren verwendungen
DE69806465D1 (de) Eine heteroethynylen-brücke enthaltende bi-aromatische verbindungen und diese enthaltende pharmazeutische und kosmetische zusammensetzungen
DK197689A (da) Pyridazinderivater
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
DE68901656D1 (de) Pharmazeutische zusammensetzung zur milderung der nebenwirkungen von platinhaltigen arzneimitteln.
ATE98478T1 (de) Calcitonin enthaltende pharmazeutische zusammensetzungen.
ATE145555T1 (de) Neue pharmazeutische formulierung enthaltend spiramycine
DE59004798D1 (de) Pharmazeutische Zubereitung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner